Evidence map›Paper›PMID 33264598›Full record

ArticleCell metabolism2020

SCENITH: A Flow Cytometry-Based Method to Functionally Profile Energy Metabolism with Single-Cell Resolution.

Rafael J Argüello, Alexis J Combes, Remy Char, Julien-Paul Gigan, Ania I Baaziz, Evens Bousiquot, Voahirana Camosseto, Bushra Samad, Jessica Tsui, Peter Yan and 6 more

Open access · bronzeAbstract read
In one paragraph

Article in Cell metabolism, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 364 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
364citing papers in PubMed, 2 pooled it
15.3field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

364 citing papers in PubMed, 2 syntheses or guidelines pooled it, 503 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Trial
  5. DRP1 depletion protects NK cells from hypoxia-induced dysfunction.Redox report : communications in free radical research · 2026
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article

304 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 3 institutions in 3 countries.

Rafael J ArgüelloAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France. Electronic address: arguello@ciml.univ-mrs.fr.
Alexis J CombesDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA, USA.
Remy CharAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Julien-Paul GiganAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Ania I BaazizAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Evens BousiquotAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France.
Voahirana CamossetoAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France; Institute for Research in Biomedicine (iBiMED) and Ilidio Pinho Foundation, Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal.
Bushra SamadDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA, USA.
Jessica TsuiDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA, USA.
Peter YanDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA, USA.
Sebastien BoissonneauAix-Marseille Univ, Institut de Neurosciences des Systems, Faculté de Medecine, Marseille, France.
Dominique Figarella-BrangerAix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service d'Anatomie Pathologique et de Neuropathologie, Marseille, France.
Evelina GattiAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France; Institute for Research in Biomedicine (iBiMED) and Ilidio Pinho Foundation, Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal; International Associated Laboratory (LIA) CNRS "Mistra", 13288 Marseille Cedex 9, France.
Emeline TabouretAix-Marseille Univ, APHM, CNRS, INP, Inst Neurophysiopathol, CHU Timone, Service de Neurooncologie, Marseille, France.
Matthew F KrummelDepartment of Pathology, University of California, San Francisco, San Francisco, CA, USA; ImmunoX Initiative, University of California, San Francisco, San Francisco, CA, USA.
Philippe PierreAix Marseille Univ, CNRS, INSERM, CIML, Centre d'Immunologie de Marseille-Luminy, Marseille, France; Institute for Research in Biomedicine (iBiMED) and Ilidio Pinho Foundation, Department of Medical Sciences, University of Aveiro, 3810-193 Aveiro, Portugal; International Associated Laboratory (LIA) CNRS "Mistra", 13288 Marseille Cedex 9, France.
Centre National de la Recherche Scientifique · FRUniversity of California, San Francisco · USInstitut de Neurosciences des Systèmes · FR

Funding

Integrating targeted and immunotherapy to treat genetically heterogeneous cancersU01CA217864 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI BALMAIN, ALLAN, KRUMMEL, MATTHEW F · 2017 to 2021
$5.1M
The Tumor Microenvironment Niche of Type I conventional Dendritic CellsR01CA197363 · NCI · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI MATTHEW F KRUMMEL · 2017 to 2026
$4.5M
NCI NIH HHS R01 CA197363NCI NIH HHS U01 CA217864
6 · The paper itself

Abstract

Energetic metabolism reprogramming is critical for cancer and immune responses. Current methods to functionally profile the global metabolic capacities and dependencies of cells are performed in bulk. We designed a simple method for complex metabolic profiling called SCENITH, for single-cell energetic metabolism by profiling translation inhibition. SCENITH allows for the study of metabolic responses in multiple cell types in parallel by flow cytometry. SCENITH is designed to perform metabolic studies ex vivo, particularly for rare cells in whole blood samples, avoiding metabolic biases introduced by culture media. We analyzed myeloid cells in solid tumors from patients and identified variable metabolic profiles, in ways that are not linked to their lineage or their activation phenotype. SCENITH's ability to reveal global metabolic functions and determine complex and linked immune-phenotypes in rare cell subpopulations will contribute to the information needed for evaluating therapeutic responses or patient stratification.

Indexed as

Energy MetabolismMetabolomeAdultAnimalsCells, CulturedFemaleFibroblastsHumansMaleMice, Inbred C57BLMiddle AgedNeoplasmsSingle-Cell Analysiscell culture media and metabolismfunctional assay metabolism single cellsmetabolic function by flow cytometrymetabolic gene signaturesmetabolic profiling of blood samplesmetabolism analysis in samples from patientsprotein synthesis and metabolismtranslation and metabolismtumor immunometabolism

Identifiers

PMID33264598
PMCPMC8407169
OpenAlexW3108924494

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.